SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-020841
Filing Date
2023-05-11
Accepted
2023-05-11 07:30:46
Documents
13
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vera-20230511.htm   iXBRL 8-K 66998
2 EX-99.1 vera-ex99_1.htm EX-99 146798
  Complete submission text file 0000950170-23-020841.txt   345523

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vera-20230511.xsd EX-101.SCH 2446
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vera-20230511_lab.xml EX-101.LAB 13904
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vera-20230511_pre.xml EX-101.PRE 11413
7 EXTRACTED XBRL INSTANCE DOCUMENT vera-20230511_htm.xml XML 4896
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 23908835
SIC: 2834 Pharmaceutical Preparations